NEFL and COVID-19: Interestingly, severe COVID-19 patients show a decrease in GFAP levels between initial (a mean of 13 days after onset of symptoms) and follow-up tests (a mean of 11.4 days after initial test), yet an increase in NfL, suggesting initial astrocyte activation followed by delayed neuronal injury (110).